BIOTRONIK announced that the Baptist Health Lexington team completed their first BIO-LivIQ study implant.
Public source
Publisher name
Public post
Congratulations to the Baptist Health Lexington team on your first BIO-LivIQ study implant! Thank you for your continued partnership. Caution: Investigational Device. Li…
Company
BIOTRONIK
Excellence for Life™️
- Industry
- Medical Equipment Manufacturing
- Location
- Berlin, DE
- Company size
- 1,001–5,000 employees
About BIOTRONIK
For over 60 years, BIOTRONIK has stood at the forefront of medical technology, pioneering breakthrough innovations that are transforming the lives of millions affected by heart disease and chronic pain. Rooted in a deep purpose to seamlessly harmonize technology with the human body, we engineer trusted, life-changing therapies through our advanced active implants in Cardiac Rhythm Management, Monitoring, and Neuromodulation, while providing cutting-edge solutions in Electrophysiology. From creating Germany’s first pacemaker in 1963 to breaking new ground in digital technologies and Conduction System Pacing today, BIOTRONIK is continuously raising the bar for quality, performance, and innovation. Headquartered in Berlin, our global reach spans over 100 countries across the Americas, EMEA, and Asia—bringing bold, future-ready solutions that are shaping the next generation of medical technology. Are you interested in a career at BIOTRONIK? Take a look at our website www.biotronik.com/careers
See moreLatest activity
Latest activity from BIOTRONIK
6 signals
Research & Knowledge
BIOTRONIK congratulated the South Denver Cardiology Associates team on their first Bio-LivIQ study implant.
Presence & Recognition
BIOTRONIK is exhibiting at the CIRSE 2026 congress in Copenhagen on September 5-9 to test Zero-Gravity.
Research & Knowledge
BIOTRONIK announced that the Sarasota Memorial Health Care System team participated in their first BIO-LivIQ study implant.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Shockwave Medical
Shockwave Medical published results from a real-world study of the ShockwaveReducer in UK hospitals over a 10-year period published by Drs. Ranil De Silva and Kevin Cheng at the Royal Brompton and Harefield hospitals and Imperial College London.
Research & Knowledge
atHeart Medical
atHeart Medical shared mid-term data from the ASCENT ASD Study presented at PICS 2026 in San Diego, showing clinically significant closure and safety profile for the reSept ASD Occluder.
Products & Services
CVRx | Barostim
CVRx | Barostim announced that the team at Harzklinikum Dorothea Christiane Erxleben successfully completed their first Barostim implant.
Research & Knowledge
AtriCure, Inc.
AtriCure, Inc. presented new data at the ESC2026 meeting led by Associate Prof. Dr. Riyaz Kaba, demonstrating significantly greater freedom from atrial arrhythmias after hybrid epicardial-endocardial ablation compared to catheter ablation alone in patients with persistent and long-standing persistent Afib and reduced left ventricular ejection fraction.
Research & Knowledge
EBR Systems, Inc.